RAD51 expression and prognostic impact in patients with stomach adenocarcinoma
Background Stomach adenocarcinoma (STAD) is the most common gastrointestinal cancer. A clear diagnosis and molecular targeted therapy have important implications for prolonging survival of patients. RAD51 is the central catalyst of homologous recombination that plays important role in maintaining ge...
| 出版年: | PeerJ |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
PeerJ Inc.
2025-04-01
|
| 主題: | |
| オンライン・アクセス: | https://peerj.com/articles/19179.pdf |
